CATEGORIES & HEADINGSdetails >>
Creoptix is revolutionizing the study of label-free molecular interactions and changing the world of drug discovery.
Now with four parallel flow channels and more additional features the new Creoptix WAVEdelta lets you ride the next wave of kinetics analysis.
Join us on the cutting edge of kinetics analysis with a technology that offers:
The most robust microfluidics
For the first time ever, drug researchers can enjoy:
A level of sensitivity superior to Surface Plasmon Resonance (SPR)
A crude sample robustness normally only achieved with plate-based assays
So welcome to the future kinetics analysis. Where will the WAVE take you?